Lv5
1498 积分 2021-03-23 加入
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
11小时前
已完结
GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective
10天前
已完结
Aggregation of Adverse Event Terms for Signal Detection and Labeling in Clinical Trials
18天前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
22天前
已完结
Efficacy and Safety of the Combination or Monotherapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: An update Systematic Review and Meta-analysis
1个月前
已完结
A genome-wide association analysis reveals new pathogenic pathways in gout*
1个月前
已完结
Pharmaceutical Medicine
2个月前
已关闭
Pharmaceutical Medicine
2个月前
已关闭
Artificial intelligence in drug development
2个月前
已完结
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
2个月前
已完结
皖公网安备34019202002308
